Organon & Co | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Celltrion KRW 195.49B 78.5B 2025-03
Cspc Pharmaceutical CNY 833.21M 111.17M 2024-12
Dianthus Therapeutics USD -28440000 3.27M 2024-12
Divis Laboratories Ltd 7.33B 1.31B 2025-06
Gilead Sciences USD 2.43B 780M 2025-06
Glaxosmithkline USD 1.66B 1.78B 2024-12
Kangmei Pharma -5720000 15.38M 2024-09
Knight Therapeutics CAD -7144000 19.01M 2024-03
Laboratorios Farma 121.55M 84.42M 2024-12
Medical Developments International AUD -6390000 0 2023-12
Merck USD 6.77B 864M 2025-06
Neuren Pharmaceuticals AUD 171.1M 159.25M 2024-12
Novartis USD 4.66B 269M 2024-12
Organigram Holdings CAD -22957000 4.15M 2024-12
Organon & Co 229M 128M 2025-06
Pharma Mar EUR 23.35M 27.26M 2025-06
Qiagen NV USD 126.82M 7.27M 2025-06
Sartorius EUR 70.9M 28.6M 2025-06
Tilray USD -83239000 49.47M 2024-11


Organon & Co L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.